Charles Schwab Investment Management »

Immix Biopharma shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $250k 28k 9.11

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us L (FNDX)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Schwab Strategic Tr Fundamental Intl (FNDF)
Chevron Corporation (CVX)
Home Depot (HD)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Merck & Co (MRK)

View all positions for Charles Schwab Investment Management

Top funds holding Immix Biopharma

Henderson Group
Saturn V Capital Management
Eventide Asset Management
Vanguard Capital Management
Millennium Management
Marshall Wace
Logos Global Management
Bleichroeder
Franklin Resources
Velan Capital Investment Management
Susquehanna International
Blue Owl Capital Holdings
BlackRock
Geode Capital Management
LGT Fund Management

View all funds holding Immix Biopharma